Concepedia

P. Erbel

PE

Statistics

Publications

30

Citations

2.3K

H-Index

25

Active since

1999

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

The University of Texas Southwestern Medical Center

Utrecht University

Novartis (United States)

P. Erbel is an author at Novartis (Switzerland) specializing in life sciences, molecular biology, and structural biology.

ORCID

Publications per year

1999–2021

30

Publications

30

Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus

P. Erbel, Nikolaus Schiering, A. D’Arcy et al. · Nature Structural & Molecular Biology · 2006 · 575 citations

, , +16

Structural basis for PAS domain heterodimerization in the basic helix–loop–helix-PAS transcription factor hypoxia-inducible factor

P. Erbel, Paul B. Card, Ozgur Karakuzu et al. · Proceedings of the National Academy of Sciences · 2003 · 227 citations · Full text

, , +14

Small-molecule factor B inhibitor for the treatment of complement-mediated diseases

Anna Schubart, Karen Anderson, Nello Mainolfi et al. · Proceedings of the National Academy of Sciences · 2019 · 216 citations · Full text

, , +17

Crystal Structure of NLRP3 NACHT Domain With an Inhibitor Defines Mechanism of Inflammasome Inhibition

Carien Dekker, Henri Mattes, Michael Wright et al. · Journal of Molecular Biology · 2021 · 160 citations

, , +16

Structural Basis of ARNT PAS-B Dimerization: Use of a Common Beta-sheet Interface for Hetero- and Homodimerization

Paul B. Card, P. Erbel, Kevin H. Gardner · Journal of Molecular Biology · 2005 · 142 citations

, , +16

1–5 of 30